Cue Biopharma, Inc.CUENASDAQ
LOADING
|||
Switch Symbol:
Revenue Growth Under Pressure
Trending lower, below historical average.
Left:
||||
Year-over-year revenue growth rate
Latest
-27.25%
↓ 150% below average
Average (38q)
54.56%
Historical baseline
Range
High:639.04%
Low:-97.40%
Volatility
1349.8%
High variability
| Period | Value |
|---|---|
| Q3 2025 | -27.25% |
| Q2 2025 | 601.66% |
| Q1 2025 | -73.29% |
| Q4 2024 | -52.76% |
| Q3 2024 | 25.51% |
| Q2 2024 | 54.80% |
| Q1 2024 | -5.71% |
| Q4 2023 | -13.29% |
| Q3 2023 | 51.95% |
| Q2 2023 | 639.04% |
| Q1 2023 | 23.84% |
| Q4 2022 | 122.06% |
| Q3 2022 | 161.54% |
| Q2 2022 | -97.40% |
| Q1 2022 | -87.89% |
| Q4 2021 | 244.65% |
| Q3 2021 | -12.56% |
| Q2 2021 | 76.37% |
| Q1 2021 | 226.72% |
| Q4 2020 | -32.48% |
| Q3 2020 | -34.51% |
| Q2 2020 | 19.44% |
| Q1 2020 | -14.23% |
| Q4 2019 | 6.64% |
| Q3 2019 | -6.73% |
| Q2 2019 | 185.14% |
| Q1 2019 | 11.92% |
| Q4 2018 | -26.37% |
| Q3 2018 | 161.05% |
| Q2 2018 | 0.00% |
| Q1 2018 | 0.00% |
| Q4 2017 | 0.00% |
| Q3 2017 | 0.00% |
| Q2 2017 | 0.00% |
| Q1 2017 | 0.00% |
| Q4 2016 | 0.00% |
| Q3 2016 | 0.00% |
| Q2 2016 | 0.00% |
| Q1 2016 | 0.00% |